Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium

Michael Ceulemans; Laure Sillis; Karel Allegaert; Annick Bogaerts; Maarten De Vos; Titia Hompes; Anne Smits; Kristel Van Calsteren; Jan Y. Verbakel; Veerle Foulon

doi:10.1002/pds.5751

Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium

Michael Ceulemans^*, Laure Sillis, Karel Allegaert, Annick Bogaerts, Maarten De Vos, Titia Hompes, Anne Smits, Kristel Van Calsteren, Jan Y. Verbakel, Veerle Foulon

^*Corresponding author for this work

Pharmacy

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	e5751
Journal	Pharmacoepidemiology and Drug Safety
Volume	33
Issue number	2
DOIs	https://doi.org/10.1002/pds.5751
Publication status	Published - Feb 2024

Access to Document

10.1002/pds.5751

Cite this

Ceulemans, M., Sillis, L., Allegaert, K., Bogaerts, A., De Vos, M., Hompes, T., Smits, A., Van Calsteren, K., Verbakel, J. Y., & Foulon, V. (2024). Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium. Pharmacoepidemiology and Drug Safety, 33(2), Article e5751. https://doi.org/10.1002/pds.5751

@article{3cca986129e24948a631cd787af02a21,

title = "Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium",

author = "Michael Ceulemans and Laure Sillis and Karel Allegaert and Annick Bogaerts and {De Vos}, Maarten and Titia Hompes and Anne Smits and {Van Calsteren}, Kristel and Verbakel, {Jan Y.} and Veerle Foulon",

year = "2024",

month = feb,

doi = "10.1002/pds.5751",

language = "English",

volume = "33",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley & Sons Ltd.",

number = "2",

}

Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium. / Ceulemans, Michael; Sillis, Laure; Allegaert, Karel et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 33, No. 2, e5751, 02.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Letter to the Editor re Davis et al., 2023

T2 - BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium

AU - Ceulemans, Michael

AU - Sillis, Laure

AU - Allegaert, Karel

AU - Bogaerts, Annick

AU - De Vos, Maarten

AU - Hompes, Titia

AU - Smits, Anne

AU - Van Calsteren, Kristel

AU - Verbakel, Jan Y.

AU - Foulon, Veerle

PY - 2024/2

Y1 - 2024/2

UR - http://www.scopus.com/inward/record.url?scp=85183674273&partnerID=8YFLogxK

U2 - 10.1002/pds.5751

DO - 10.1002/pds.5751

M3 - Comment/Letter to the editor

C2 - 38362651

AN - SCOPUS:85183674273

SN - 1053-8569

VL - 33

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 2

M1 - e5751

ER -

Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium

Access to Document

Other files and links

Cite this